News Boston Scientific Corporation

Equities

BSX

US1011371077

Real-time Estimate Cboe BZX Other stock markets 12:12:30 2024-04-16 pm EDT			5-day change	1st Jan Change
68.32 ^USD	+1.31%		-0.47%	+18.21%

Apr. 15	Integer Holdings to Benefit from Pulsed Field Ablation Market Growth, BofA Says	MT
Apr. 15	Truist Securities Adjusts Boston Scientific Price Target to $79 From $73, Buy Rating Kept	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Welcome Labour Court Decision On Continuity Of Service When Agency Worker Transitioned To Client Employee	04:09am	AQ
Integer Holdings to Benefit from Pulsed Field Ablation Market Growth, BofA Says	Apr. 15	MT
Truist Securities Adjusts Boston Scientific Price Target to $79 From $73, Buy Rating Kept	Apr. 15	MT
BTIG Adjusts Boston Scientific's Price Target to $74 From $72	Apr. 15	MT
RBC Raises Price Target on Boston Scientific to $78 From $70, Keeps Outperform Rating	Apr. 15	MT
Penumbra, Inc. : The underdog in healthcare	Apr. 11
Nectero Medical LLC announced that it has received $96 million in funding from Boston Scientific Corporation, NVP Associates, LLC, BioStar Ventures LLC, Cadence Healthcare Ventures, Llc, Aphelion Capital, LLC and other investors	Apr. 10	CI
Boston Scientific : Two employees share their passion for helping people with Parkinson’s disease	Apr. 10	PU
Boston Scientific Starts Study of Software Module, Catheter for Treatment of Atrial Fibrillation	Apr. 08	MT
Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module	Apr. 08	PR
Boston Scientific, Axonics Receive FTC Second Request on Merger Deal	Apr. 04	MT
Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information	Apr. 04	DJ
FTC seeks additional information for Boston Scientific's $3.7 bln Axonics deal	Apr. 04	RE
Argus Raises Boston Scientific's Price Target to $80 From $69, Keeps Buy Rating	Apr. 03	MT
Citigroup Adjusts Price Target on Boston Scientific to $79 From $71, Keeps Buy Rating	Apr. 03	MT
Boston Scientific Insider Sold Shares Worth $1,133,069, According to a Recent SEC Filing	Apr. 03	MT
Boston Scientific Insider Sold Shares Worth $477,777, According to a Recent SEC Filing	Apr. 03	MT
Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results	Apr. 01	PR
Protembis Announces Completion of EUR 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors	Mar. 27	AQ
Scivita Medical Technology Co., Ltd. and Boston Scientific Corporation Sign an Expanded Strategic Cooperation Arrangement	Mar. 25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Boston Scientific Corporation

Equities

BSX

US1011371077

Summary

Filters